We provide evidence that insulin signal transduction in CF cells is impaired, is characterized mainly by reduced FOXO1 content, that these changes are related with CFTR loss of function, and that IGF-I is effective in increasing FOXO1 content both in vitro, and in vivo in skeletal muscle. The gene discussed is CFTR; the disease is cystic fibrosis.